(Q44698193)

5 December 2017

0 references

Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis (English)

1 reference

5 December 2017

main subject

obstructive sleep apnea

1 reference

1 reference

Yongzhong Guo

1

1 reference

5 December 2017

Lei Pan

series ordinal

2

1 reference

5 December 2017

Dunqiang Ren

series ordinal

3

1 reference

5 December 2017

Xiaomei Xie

series ordinal

4

1 reference

5 December 2017

publication date

5 June 2012

1 reference

5 December 2017

1 reference

5 December 2017

volume

17

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

495-503

1 reference

Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Elevated C-reactive protein in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Decreased lipoprotein lipase in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Reduction of serum retinol-binding protein-4 levels in nondiabetic obstructive sleep apnea patients under continuous positive airway pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Association between lipid peroxidation and inflammation in obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Daytime sleepiness in the obese: not as simple as obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

C-reactive protein and sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Reduction of C-reactive protein with surgical treatment of obstructive sleep apnea hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-012-0722-2

[Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome]

21 January 2018

1 reference

12 December 2020

[Hemodynamic and inflammatory markers of sleep apnea-hypopnea syndrome and nocturnal hypoxemia: effects of treatment with nasal continuous positive airway pressure]

1 reference

12 December 2020

Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults

1 reference

12 December 2020

Obstructive sleep apnea as a risk factor for cardiovascular diseases.

1 reference

12 December 2020

C-reactive protein: a new risk assessment tool for cardiovascular disease.

1 reference

12 December 2020

Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

1 reference

12 December 2020

10.1007/S11325-012-0722-2

Identifiers

DOI

1 reference

release_otqhgngbqrfjbmq2e4bxd4liia

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/otqhgngbqrfjbmq2e4bxd4liia

24 November 2022

mapped directly with Wikidata item

1 reference